Transgenic Plants for High Yield Terpenoid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for increasing terpenoid production in plants are limited, with conventional approaches only manipulating the plastidial MEP pathway and resulting in modest increases, typically a 2-fold increase at best.
Innovation Solution
Transgenic plants are developed that overexpress specific heterologous nucleic acids encoding polypeptides with 3-hydroxy-3-methylglutarylCoA reductase (HMGR) activity and phosphomevalonate kinase (PMK) or phosphomevalonate decarboxylase (MPD) activity, leading to increased terpenoid biosynthesis by enhancing the metabolically available isopentenyl phosphate (IP).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional approaches manipulate only the plastidial MEP pathway to increase terpenoid production, then terpenoid production is increased, but the increase is limited to at most 2-fold
Solution Approach 1:
The invention segments the terpenoid biosynthesis enhancement into multiple independent pathway manipulations: (1) overexpression of HMGR in the cytosolic MVA pathway, (2) overexpression of PMK or MPD enzymes, and (3) manipulation of the plastidial MEP pathway. This segmentation allows each pathway to be optimized independently, achieving synergistic effects that exceed the 2-fold limit of single-pathway manipulation.
Solution Approach 2:
The invention merges multiple biosynthetic pathways (MVA, MEP, and alternative MVA) into a coordinated system for terpenoid production. By simultaneously enhancing flux through all three pathways and integrating them at the level of IPP/DMAPP supply, the system achieves high-yield terpenoid production that cannot be obtained by manipulating a single pathway alone.
2Productivity
If heterologous nucleic acids encoding HMGR and PMK/MPD are overexpressed, then terpenoid biosynthesis is significantly increased (20-fold for monoterpenes, 130-fold for sesquiterpenes), but the genetic engineering complexity increases
Solution Approach 1:
The invention uses universal promoter elements and standardized genetic constructs that can be applied across different plant species and terpenoid targets. The heterologous nucleic acid constructs encode enzymes (HMGR, PMK, MPD) that function universally in plant cellular contexts, allowing the same engineering approach to be deployed for producing different terpenoid classes (monoterpenes, sesquiterpenes) without redesigning the core expression system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The transgenic plants achieve significant increases in terpenoid production, with monoterpene and sesquiterpene production increasing by up to 20-fold and 130-fold, respectively, compared to wild-type plants, thereby overcoming the limitations of conventional methods.
Implementation Method 1
a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase (HMGR) activity
Implementation Method 2
a polypeptide having phosphomevalonate kinase (PMK) activity
Implementation Method 3
a polypeptide that introduces de novo formation of isopentenyl phosphate (IP) in the transgenic plant
Data Source
AI summary
Transgenic plants and methods for terpenoid production leveraging such transgenic plants are provided. Such transgenic plants may comprise a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase activity and a second heterologous nucleic acid encoding a polypeptide that introduces de novo formation of isopentenyl phosphate in the plant. Such de novo IP production may be achieved through the overexpression of phosphomevalonate decarboxylase in conjunction with 3-hydroxy-3-methylglutarylCoA reductase, which can result in up to a 130-fold increase of terpenoid production as compared to a wild-type plant.